# Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease

> **NCT02366845** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 50 (actual)

## Conditions studied

- Liver Disease

## Interventions

- **BIOLOGICAL:** Fresh Frozen Plasma
- **DIAGNOSTIC_TEST:** Pre-Transfusion International Normalized Ratio (INR)
- **DIAGNOSTIC_TEST:** Post-Transfusion International Normalized Ratio (INR)

## Key facts

- **NCT ID:** NCT02366845
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-27
- **Primary completion:** 2015-06-24
- **Final completion:** 2019-03-27
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02366845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02366845, "Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02366845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*